Studies reveal red blood cells contribute to endothelial dysfunction in diabetes, suggesting new treatment targets.
Diabetes induces many pathological alterations within RBCs which have been shown to be transmitted to endothelial cells and elicit endothelial dysfunction. The role of RBCs as key players in eliciting endothelial dysfunction represent a major paradigm shift in our understanding of diabetes-induced vascular dysfunction and thus, RBCs might represent a novel therapeutic target in cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Hassanein et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: